Pzena Investment Management LLC Sells 721,663 Shares of Envista Holdings Corporation $NVST

Pzena Investment Management LLC trimmed its stake in shares of Envista Holdings Corporation (NYSE:NVST) by 31.0% during the first quarter, HoldingsChannel reports. The fund owned 1,604,196 shares of the company’s stock after selling 721,663 shares during the period. Pzena Investment Management LLC’s holdings in Envista were worth $40,698,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Millennium Management LLC increased its holdings in Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after purchasing an additional 2,263,712 shares in the last quarter. Holocene Advisors LP acquired a new position in shares of Envista during the second quarter worth about $43,936,000. Norges Bank bought a new position in shares of Envista during the fourth quarter worth about $45,113,000. Alliancebernstein L.P. grew its holdings in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after buying an additional 1,547,656 shares in the last quarter. Finally, Freestone Grove Partners LP acquired a new stake in Envista in the 4th quarter valued at approximately $29,046,000.

Envista Price Performance

Shares of NYSE NVST opened at $27.21 on Thursday. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. The business’s 50 day moving average price is $24.84 and its two-hundred day moving average price is $25.21. The company has a market cap of $4.43 billion, a PE ratio of 66.37, a price-to-earnings-growth ratio of 1.49 and a beta of 0.86. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business had revenue of $705.50 million during the quarter, compared to the consensus estimate of $680.03 million. During the same quarter in the previous year, the firm posted $0.24 EPS. Envista’s revenue was up 14.4% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, analysts predict that Envista Holdings Corporation will post 1.42 EPS for the current year.

Analyst Upgrades and Downgrades

NVST has been the topic of several research reports. Citigroup began coverage on Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 target price on the stock. Barclays lowered their price objective on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Evercore reissued an “outperform” rating and issued a $33.00 price objective on shares of Envista in a research report on Thursday, May 7th. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Finally, JPMorgan Chase & Co. raised their target price on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $28.67.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.